DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas will join the panel, “How the Other Half Lives: What’s Happening in Venture and Why it Matters” at the BIO CEO Investor conference.
News | 02. 11. 2013
Art Pappas will join the panel, “How the Other Half Lives: What’s Happening in Venture and Why it Matters” at the BIO CEO Investor conference.
